A prototype-stage diagnostic platform program under engineering development. Dr. POCT is being designed to explore compact, AI-assisted, cartridge-based diagnostic workflows for future decentralised healthcare environments across India and similar settings.
The problem we are addressing
of primary health centres in rural India have functional laboratory diagnostic capability beyond basic rapid tests.
is the average time between clinical presentation and laboratory-confirmed diagnosis in non-urban India — a window in which manageable conditions can become life-threatening.
Our research approach
Dr. POCT is BIQADX's prototype-stage exploration of a fundamentally different architecture for point-of-care diagnostics. Rather than sending a sample to infrastructure, the concept brings intelligent diagnostic processing to the point of care — with enough analytical capability to support real clinical decision-making.
Dr. POCT is designed around a sealed, single-use biodegradable cartridge that contains everything needed for sample preparation, analysis-ready processing, and quality control verification. The instrument reads the cartridge using an integrated optical and electrochemical sensing array and processes results through an on-device AI inference engine. No external reagents. No cold chain dependency. No specialist operator required.
The platform's intended workflow is simple: a healthcare worker inserts a small blood or other biological sample via fingerprick or standard collection, loads a sealed cartridge, and receives AI-assisted, QC-verified results on the instrument display — with an optional secure cloud transmission to a connected health record system.
What it's for
Dr. POCT Duo Lab brings dual-capability lab testing to the bedside and beyond — lab-grade answers where you need them, in a form that travels.
Intended deployment
A single health worker in a PHC 40 km from the nearest district hospital. A patient presents with suspected infection. The worker collects a fingerprick sample, inserts a sealed cartridge, and receives a quality-verified result in minutes — enough to decide: treat, refer, or reassure. No sample is sent away. No second visit is needed.
A government-run immunisation and screening camp in a remote block. Dr. POCT travels in a backpack. Over a single day, dozens of patients are screened for conditions that would otherwise go undetected until they become emergencies.
A hospital ward where lab results currently take hours. A bedside Dr. POCT delivers time-sensitive answers — infection markers, metabolic panels — fast enough to guide the treatment decision that cannot wait for the central lab queue.
Intended specifications
These are design-intent specifications, not validated performance claims. All figures represent engineering targets for a platform in prototype / engineering development.
Compact portable, designed to fit in a standard field-kit bag
Fingerprick capillary blood, with a single-drop target volume
Sealed, single-use, biodegradable cartridge through the EcoLabware program
Dual-mode optical and electrochemical sensing as a design target
Edge-deployed neural inference, designed to work offline
Automated quality-gating before result release
Structured HL7/FHIR R4 output as a design target
Rechargeable battery for intermittent-power environments
Offline-first operation with optional secure data transmission
Under ₹400 per test as a design goal, not a current price
Prototype / engineering development
Why it matters
The rigour, accuracy, and quality-gating of a central laboratory — compressed into a device designed for the bedside, the PHC, and the field. The goal is that no patient should have to travel to a laboratory for an answer the platform can deliver on the spot.
Dual sensing modalities in a single instrument — optical and electrochemical — so one device and one sample can answer questions that currently require two separate workflows.
Results delivered fast enough to guide the treatment decision being made right now — not a result that arrives after the patient has already left, already been treated empirically, or already deteriorated.
A workflow so simple that a community health worker with minimal laboratory training can operate the device confidently. If the platform requires a specialist, it has failed its own design brief.
The lab no longer waits behind a door.
Questions
It is designed to bring dual-capability lab testing to the bedside and beyond — framed at a high level here, without revealing the underlying mechanism.
Built for point-of-care and bedside teams, and for the wider mission of reaching communities beyond centralised healthcare.
BIQADX is at a pre-clinical, prototype stage — Dr. POCT Duo Lab is not currently available for commercial sale. We welcome partnership and pilot conversations.